Chief Legal Officer · ANAPTYSBIO, INC (ANAB)

Eric Loumeau

A named executive officer of ANAPTYSBIO in every fiscal year CompBrief holds from FY2018 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$2,258,185

Salary $493,823Stock awards $515,241

FY2022: $3,841,763

3rd of 3 named executive officers at Anaptysbio by FY2023 total.

3 named officers on file for ANAPTYSBIO, FY2023

Eric Loumeau’s pay file — $29

  • 6 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing
  • ANAB’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ANAPTYSBIO’s whole pay program stands against its peers

  • ANAPTYSBIO’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ANAB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 24, 2024 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Eric Loumeau’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Eric Loumeau compensation by year

ANAPTYSBIO Summary Compensation Table · all 6 fiscal years held
In US dollars, as ANAPTYSBIO reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2020FY2021FY2022FY2023
Salary$148,106$381,000$399,025$461,000$474,830$493,823
Bonus$0—$0$0$0$0
Stock awards$0$0$0$0$283,440$515,241
Option awards$1,961,388$3,060,804$149,991$1,015,911$2,872,730$1,020,941
Non-equity incentive$54,763$91,440$168,000$168,553$197,648$197,529
Pension and deferred compensation$0$0$0$0$0$0
All other$774$8,322$8,322$10,322$13,115$30,650
Total$2,165,031$3,541,566$725,338$1,655,786$3,841,763$2,258,185

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ANAPTYSBIO, INC DEF 14A filed April 24, 2024, accession 0001370053-24-000019, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ANAPTYSBIO, INC filed document, accession 0001370053-24-000019. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2024.

$2.2M
$3.5M
$725K
$1.7M
$3.8M
$2.3M
FY18
FY19
FY20
FY21
FY22
FY23
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU22,180$475,096—
RSU6,000$128,520—
Option1,458—$20.16
Option37,917—$30.44
Option15,000—$28.64
Option60,530—$23.23
Option13,125—$29.70

Per the Outstanding Equity Awards at Fiscal Year-End table in ANAPTYSBIO, INC's FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

49 Form 4 lines since the FY2023 proxy (filed April 24, 2024)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-02-11Exercise or conversion derivative10b5-110,000$0.0035,000
2026-02-11Sale10b5-110,000$54.0012,835
2026-02-11Exercise or conversion10b5-110,000$29.7022,835
2026-01-08Sale—2,210$44.7112,835
2026-01-07Exercise or conversion—5,888—15,045
2026-01-07Exercise or conversion derivative—5,888$0.0017,662
2026-01-07Sale—500$47.239,157
2026-01-07Sale—1,841$46.139,657

The 8 most recent of 49 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

ANAPTYSBIO’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Daniel FagaPresident and Chief Executive Officer and Director$7,461,920
Paul LizzulChief Medical Officer$2,441,117
Eric Loumeau · this pageChief Legal Officer$2,258,185

The full ANAPTYSBIO compensation record

free company brief

This page is one person within ANAPTYSBIO's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ANAPTYSBIO's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Eric Loumeau's compensation dossier · One-time report. No refunds.